Robert M. Davis
2021 - Merck & Co.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $235,640 |
|---|---|
| Non-Equity Incentive Plan | $2,834,606 |
| Option Awards | $2,760,003 |
| Salary | $1,319,959 |
| Stock Awards | $6,324,576 |
| Other | $247,337 |
| Total | $13,722,121 |
Davis received $6.3M in stock awards, accounting for 46% of the total pay in 2021.
Davis also received $235.6K of change in pension value and nonqualified deferred compensation earnings, $2.8M in non-equity incentive plan, $2.8M in option awards, $1.3M in salary and $247.3K in other compensation.
Rankings
In 2021, Robert M. Davis' compensation ranked 645th out of 12,412 executives tracked by ExecPay. In other words, Davis earned more than 94.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 645 out of 12,412 | 95th |
Division Manufacturing | 212 out of 5,498 | 96th |
Major group Chemicals And Allied Products | 69 out of 2,374 | 97th |
Industry group Drugs | 59 out of 2,095 | 97th |
Industry Pharmaceutical Preparations | 35 out of 1,542 | 98th |
Pay ratio
| Robert M. Davis' Pay | $13,722,121 |
|---|---|
| Median Employee's Pay | $102,803 |
| Pay Ratio | 133to 1 |
In 2021, the annual total compensation of Robert M. Davis was $13,722,121.
The annual total compensation of the median employee at Merck & Co. was $102,803.
The ratio of Robert M. Davis' pay to the pay of median employee was therefore 133 to one.
Davis' colleagues
We found five more compensation records of executives who worked with Robert M. Davis at Merck & Co. in 2021.
2021
Kenneth Frazier
Merck & Co.
Chief Executive Officer
2021
Frank Clyburn
Merck & Co.
Former Executive Vice President and President, Human Health
2021
Richard DeLuca
Merck & Co.
Executive Vice President and President, Merck Animal Health
2021
Dean Li
Merck & Co.
Executive Vice President and President, Merck Research Laboratories
2021
Caroline Litchfield
Merck & Co.